HGH Fragment 176-191 Research: Lipolysis Mechanism and Study Overview

HGH Fragment 176-191 is a synthetic peptide derived from the C-terminal region of human growth hormone. Unlike full-length GH, it does not stimulate IGF-1 production or promote cell proliferation — instead, it selectively targets fat metabolism pathways. This specificity has made it a valuable tool compound in lipolysis and metabolic research.

What Is HGH Fragment 176-191?

HGH Fragment 176-191 (also known as AOD-9604) corresponds to amino acids 176 through 191 of the full human growth hormone sequence. This region of the GH molecule is responsible for the lipolytic activity of GH, while the growth-promoting and insulin-desensitizing effects are attributed to other regions of the molecule. By isolating this fragment, researchers can study fat metabolism effects independently of the anabolic and diabetogenic properties of full-length GH.

Mechanism of Action

The lipolytic mechanism of HGH Fragment 176-191 has been studied primarily in rodent models and in vitro systems. Key mechanistic findings from research:

• Beta-3 adrenergic receptor interaction: The fragment appears to stimulate lipolysis through a mechanism involving beta-3 adrenergic receptors on adipocytes, similar to the lipolytic action of full-length GH
• Inhibition of lipogenesis: Research indicates the fragment inhibits the conversion of non-fatty food sources into body fat (lipogenesis), particularly relevant in high-carbohydrate diet models
• No IGF-1 stimulation: Unlike full-length GH, HGH Fragment 176-191 does not significantly elevate IGF-1 levels in research models, making it useful for isolating lipolytic effects from anabolic confounders
• No effect on blood glucose: Studies report no significant impact on insulin sensitivity or blood glucose regulation, in contrast to full-length GH which can induce insulin resistance

Research Applications

HGH Fragment 176-191 has been investigated in the following research contexts:

• Lipolysis research: Primary application — studying selective fat breakdown in adipose tissue without the confounding anabolic effects of full-length GH
• Obesity and metabolic research: Used in diet-induced obesity models to examine fat mass reduction and metabolic rate changes
• Body composition studies: Investigated for differential effects on fat mass vs. lean mass in rodent models
• Lipogenesis inhibition: Studied as a tool to examine the molecular pathways of fat storage suppression
• AOD-9604 clinical research: The compound was evaluated in human clinical trials under the name AOD-9604 for obesity treatment, providing a relatively rare clinical data set for a research peptide

HGH Fragment 176-191 vs Full-Length GH

The key distinction between HGH Fragment 176-191 and full-length growth hormone lies in receptor selectivity. Full-length GH binds to GH receptors broadly, stimulating IGF-1 production, promoting cell growth, and affecting glucose metabolism. HGH Fragment 176-191 retains the lipolytic signaling capacity of GH without activating the growth-promoting receptor domains. This makes it a more targeted tool compound for researchers who want to study fat metabolism in isolation from the broader GH axis effects.

Relationship to the Metabolic Research Peptide Stack

In metabolic research, HGH Fragment 176-191 is sometimes studied alongside other peptides that influence body composition and energy metabolism. Retatrutide (GLP-3R) represents a complementary research direction — targeting GLP-1, GIP, and GCGR receptors for multi-pathway metabolic modulation — while HGH Fragment 176-191 provides a more targeted lipolytic tool. Together they represent different mechanistic angles in metabolic and weight research.

Summary

HGH Fragment 176-191 is a selective lipolytic peptide derived from the C-terminal region of human growth hormone. Its ability to stimulate fat breakdown without elevating IGF-1 or affecting glucose metabolism makes it a uniquely targeted tool compound for adipose tissue and metabolic research. Its clinical evaluation history under the AOD-9604 designation provides additional data context rarely available for research peptides.

All content on this page is intended for research and educational purposes only. QuickPen Pro peptides are sold exclusively for laboratory and scientific research use.